Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 2/20 | 0.56 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.56 |
| ▸ | LMNA | P02545 | 1/20 | 0.44 |
| ▸ | POLB | P06746 | 1/20 | 0.44 |
| ▸ | MAPT | P10636 | 1/20 | 0.44 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.42 |
| ▸ | P2RX7 | Q99572 | 3/20 | 0.42 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.41 |
| ▸ | PDE2A | O00408 | 1/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.40 |
| ▸ | GAA | P10253 | 2/20 | 0.40 |
| ▸ | GPR139 | Q6DWJ6 | 1/20 | 0.40 |
| ▸ | CNR1 | P21554 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23309646 | 0.84 | ALDH1A1 (0.49) | MEN1KMT2APDE2AALDH1A1GAA | |
| SCHEMBL23309724 | 0.76 | GAA (0.55) | KMT2ALMNAPOLBL3MBTL1ALDH1A1 | |
| SCHEMBL23309580 | 0.76 | KLKB1 (0.41) | LMNAMAPTALDH1A1GAA | |
| SCHEMBL5644858 | 0.76 | MEN1 (0.61) | MEN1KMT2ALMNAPOLBMAPT | |
| SCHEMBL5643654 | 0.75 | KMT2A (0.71) | MEN1KMT2ALMNAPOLBMAPT | |
| SCHEMBL10297485 | 0.74 | MEN1 (0.53) | MEN1KMT2ALMNAPOLBMAPT | |
| SCHEMBL5645329 | 0.73 | LMNA (0.60) | MEN1KMT2ALMNAPOLBMAPT | |
| SCHEMBL5643696 | 0.71 | MEN1 (0.75) | MEN1KMT2ALMNAPOLBMAPT | |
| SCHEMBL23309708 | 0.71 | RAB9A (0.52) | KMT2ALMNAPOLBP2RX7ALDH1A1 | |
| SCHEMBL19816588 | 0.70 | MEN1 (0.61) | MEN1KMT2ALMNAPOLBMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20210120817-A1 | PLANT DISEASE CONTROL AGENT | MEIJI SEIKA PHARMA CO., LTD. (JP) | 2021-04-29 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210120817-A1 | PLANT DISEASE CONTROL AGENT | BROX, ALG1, CTRL | MEN1 1633/4885KMT2A 2360/4885LMNA 3312/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.